Ensign Peak Advisors
ZBH icon

Ensign Peak Advisors’s Zimmer Biomet ZBH Stock Holding History

Ensign Peak Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Buy
28,815
+2,169
+8% +$190K ﹤0.01% 695
2026
Q1 		$2.41M Buy
26,646
+3,903
+17% +$358K ﹤0.01% 673
2025
Q4 		$2.05M Sell
22,743
-25,081
-52% -$2.38M ﹤0.01% 698
2025
Q3 		$4.71M Sell
47,824
-209,353
-81% -$20.7M 0.01% 604
2025
Q2 		$23.5M Buy
257,177
+148,481
+137% +$14.4M 0.04% 288
2025
Q1 		$12.3M Buy
108,696
+50,173
+86% +$5.37M 0.02% 406
2024
Q4 		$6.18M Buy
58,523
+4,000
+7% +$429K 0.01% 593
2024
Q3 		$5.89M Buy
54,523
+350
+0.6% +$38.2K 0.01% 583
2024
Q2 		$5.88M Buy
54,173
+38,568
+247% +$4.55M 0.01% 585
2024
Q1 		$2.06M Sell
15,605
-1,331
-8% -$166K ﹤0.01% 914
2023
Q4 		$2.06M Sell
16,936
-5,102
-23% -$569K ﹤0.01% 904
2023
Q3 		$2.47M Sell
22,038
-3,115
-12% -$396K 0.01% 767
2023
Q2 		$3.66M Buy
25,153
+5,925
+31% +$805K 0.01% 677
2023
Q1 		$2.48M Buy
19,228
+165
+0.9% +$20.7K 0.01% 754
2022
Q4 		$2.43M Buy
19,063
+622
+3% +$72.2K 0.01% 752
2022
Q3 		$1.93M Sell
18,441
-144,115
-89% -$15.8M ﹤0.01% 794
2022
Q2 		$17.1M Buy
162,556
+143,170
+739% +$17M 0.04% 291
2022
Q1 		$2.48M Sell
19,386
-5,244
-21% -$632K 0.01% 806
2021
Q4 		$3.04M Sell
24,630
-2,158
-8% -$282K 0.01% 820
2021
Q3 		$3.81M Buy
26,788
+238
+0.9% +$35K 0.01% 767
2021
Q2 		$4.15M Sell
26,550
-2,622
-9% -$425K 0.01% 729
2021
Q1 		$4.53M Sell
29,172
-3,548
-11% -$550K 0.01% 671
2020
Q4 		$4.89M Sell
32,720
-38,434
-54% -$5.43M 0.01% 616
2020
Q3 		$9.4M Buy
71,154
+3,333
+5% +$435K 0.02% 453
2020
Q2 		$7.86M Buy
67,821
+37,049
+120% +$4.27M 0.02% 480
2020
Q1 		$3.02M Sell
30,772
-3,697
-11% -$485K 0.01% 662
2019
Q4 		$5.01M Buy
+34,469
New +$4.76M 0.01% 644

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ensign Peak Advisors's ZBH Position: Q2 2026 in Review

Ensign Peak Advisors increased its Zimmer Biomet (ZBH) stake by 8.1% in Q2 2026, buying an estimated $190K and bringing the position to 28,815 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #695.

Ensign Peak Advisors first reported a position in ZBH in Q4 2019 and has held it in 27 quarters since. The position peaked at $23.5M in Q2 2025. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Ensign Peak Advisors held 28,815 shares of Zimmer Biomet worth $2.48M as of Q2 2026.
  • Ensign Peak Advisors bought 2,169 Zimmer Biomet shares in Q2 2026, an estimated $190K.
  • Zimmer Biomet made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #695 holding.
  • Ensign Peak Advisors first reported a position in Zimmer Biomet in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Zimmer Biomet position peaked at $23.5M in Q2 2025.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.